ANI Pharmaceuticals, BioSante deal

The companies announced they will merge in a stock deal with BioSante remaining as the surviving entity. After the deal, which is expected to close next quarter, former ANI shareholders will own about

Read the full 336 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE